Quote & Headlines
Market Currents
StockTalk
Today
5d
1m
3m
1y
5y
10y
52wk high:
52wk low:
EPS:
PE:
Div Rate:
Yield:
Market Cap:
Volume:
475 people get SNN articles and Market Currents by email alert.
Get email alerts on SNN »
FOCUS
|
PRO
|
RELATED
|
TRANSCRIPTS
|
NEWS & PR
-
-
-
Healthpoint Buy To Double Smith & Nephew's U.S. Wound OperationsEP Vantage • Wed, Nov 28, 2012 -
Why Smith & Nephew Is an Attractive Takeover TargetInvestment U • Mon, Jan 24, 2011 -
-
Smith & Nephew Shifts Focus to China OperationsChinaBio Today • Sat, Aug 23, 2008
-
Smith & Nephew To Market "Spine Fix" Bone CementSara Calabro • Thu, May 17, 2007
-
Smith & Nephew: Deal With Teknimed Inks Has Healthy PotentialSara Calabro • Wed, May 16, 2007
-
Smith & Nephew Buys BlueSky To Penetrate Wound Care MarketSara Calabro • Mon, May 14, 2007
To learn more about Seeking Alpha Pro, click here.
-
-
-
-
-
-
Casey Analyst Forecasts Explosive Biotech GrowthLife Sciences Report • Thu, Oct 11, 2012
-
-
4 Low-Debt Healthcare Stocks With Hefty Earnings TrendsZetaKap • Tue, Sep 4, 2012 -
-
-
-
-
-
5 Solid Healthcare Stocks To Profit FromValueMax • Tue, Feb 21, 2012 -
9 European Stocks With Impressive ProfitabilityKapitall • Thu, Jan 26, 2012
-
-
-
10 Healthcare Stocks With Consistently Rising Gross ProfitsKapitall • Wed, Dec 21, 2011
-
-
-
Smith & Nephew plc Q2 2010 Earnings Call TranscriptSat, Aug 7, 2010
-
Smith & Nephew PLC Q3 2007 Earnings Call TranscriptSun, Nov 4, 2007
-
at MarketWatch.com (Nov 28, 2012)
-
at MarketWatch.com (Aug 2, 2012)
-
at MarketWatch.com (May 3, 2012)
-
at MarketWatch.com (May 3, 2012)
-
at MarketWatch.com (Nov 14, 2011)
-
at MarketWatch.com (May 12, 2011)
-
at MarketWatch.com (Apr 18, 2011)
-
at MarketWatch.com (Apr 18, 2011)
-
at MarketWatch.com (Feb 10, 2011)
-
at MarketWatch.com (Jan 25, 2011)
-
at CNBC.com (Jan 18, 2011)
-
at MarketWatch.com (Jan 14, 2011)
-
at MarketWatch.com (Jan 10, 2011)
-
at CNBC.com (Jan 10, 2011)
-
at CNBC.com (Jan 10, 2011)
-
at CNBC.com (Jan 10, 2011)
-
at MarketWatch.com (Jan 10, 2011)
-
at MarketWatch.com (Jan 10, 2011)
-
at MarketWatch.com (Nov 5, 2010)
-
at MarketWatch.com (Aug 5, 2010)
SNN vs. ETF Alternatives
Company Description
Currently, there's no company description for SNN.
- All
- | Earnings
- | Dividends
- | M&A
- | On the move
- Thursday, February 7, 5:02 AM Smith & Nephew (SNN): Q4 EPS of 21.6 cent beats by 0.5 cents. Revenues of $1.11B (-2.7% Y/Y) beat by $10M. Declares final dividend of 16.2 cents/share, bringing the total for 2012 to 26.1 cents/share. Shares +0.35% in London. (PR) Comment! [Earnings, Healthcare]
- Thursday, January 17, 7:44 PM The FDA is concerned whether several medical devices already on the market, such as electroconvulsive therapy devices for depression and emergency defibrillators, require additional evidence to prove they're safe. It's issued a safety advisory, saying patients with symptoms suggesting their devices aren't functioning properly should be considered for testing of possible metal ions in their bloodstream. Symptoms include: skin rashes, neurological changes such as hearing and vision impairment, and psychological status changes including depression. Comment! [Healthcare]
- Wednesday, November 28, 2012, 8:07 AM Smith & Nephew (SNN) agrees to acquire Healthpoint Biotherapeutics for $782M, allowing the British medical products manufacturer to expand into the wound therapy sector. SNN expects the acquisition to exceed its cost of capital in the third full year following acquisition, to be broadly EPSA neutral in 2013 and accretive thereafter. Comment! [Healthcare, M&A]
- Friday, June 1, 2012, 10:54 AM U.K. medical device maker Smith & Nephew (SNN -3.2%) slips after saying it's withdrawing the optional metal liner component used in its hip implants, saying it isn't satisfied with clinical results. Approximately 7,700 metal liners have been implanted since the component was introduced in 2007, the majority of which have been used in stemmed total hip replacements. Comment! [Healthcare, Global & FX, On the Move]
- Thursday, May 3, 2012, 3:27 AM Smith & Nephew (SNN): Q1 trading profit of $252M vs. $241M in the year-earlier period. Excluding restructuring and acquisition costs, EPS of $0.195/share, in-line. Knee replacements and wound care helped drive the profit growth. Revenue rose to $1.08B from $1.06B, in-line with estimates. Comment! [Healthcare, Earnings]
- Monday, February 6, 2012, 12:02 PM The SEC slaps a $22M fine on Smith & Nephew (SNN +0.2%) for allegedly violating the Foreign Corrupt Practices Act with bribes paid to Greek doctors to win business. The complaint filed in federal court (.pdf) says that the company kept a slush fund to make the payments. Comment! [Healthcare]
- Wednesday, January 4, 2012, 2:48 AM Smith & Nephew (SNN) will spin off its biologics business into a new joint venture that will be majority owned by healthcare investor Essex Woodlands. Smith & Nephew will receive ~$98M in exchange, which will be used to pay down debt, and a $160M five-year note from the new JV. Comment! [M&A, Healthcare]
-
Thursday, March 17, 2011, 9:10 AM
Premarket gainers: CTIC +11%. SNE +8%. CIGX +7%. KYO +6%. SI +6%. GPL +5%. CPST +5%. FDX +5%. PC +5%. STD +5%. RDS +4%. VOD +4%. RIO +4%. TEF +4%. ARMH +4%. CREE +4%. SNN +4%. TOT +4%. ABB +4%. BBVA +4%. VE +4%. MT +4%. UPS +4%. NOK +3%. ALU +4%. HERO +3%. URRE +3%. CLF +3%. LVLT +3%. BHP +3%. STO +3%. MGM +3%.
Losers: GMR -30%. GES -7%. KWK -6%. HSOL -6%. NRP -6%. SNBC -5%. LULU -4%. PHI -4%. THQI -3%. Comment! - Wednesday, February 2, 2011, 2:50 PM Smith & Nephew (SNN +1.1%), Europe's largest maker of knee and hip replacement products, gained 16% when speculation began that Johnson & Johnson (JNJ +0.2%) was looking at a potential takeover of the company. Bloomberg calculates that it's still worth an additional 60%, or $15.6B, in an acquisition. 1 Comment
-
Tuesday, January 18, 2011, 9:00 AM
Premarket gainers: ARIA +33%. SBIB +19%. HEV +10%. CXDC +9%. VOD +5%. TGB +4%. ERJ +4%. ASTM +4%. SNN +4%.
Losers: CMA -6%. AAPL -5%. AVGO -5%. C -5%. WLOCD -4%. GSK -4%. Comment! - Sunday, January 16, 2011, 12:56 PM J&J (JNJ) is reportedly considering a new takeover approach for Smith & Nephew (SNN), which denies it's in deal talks. The Sunday Times says a bid would be worth at least 800 pence, valuing the company at more than £7B ($11B), up from a 750p/share bid reportedly rejected last year. Comment!
- Friday, January 14, 2011, 8:13 AM Smith & Nephew (SNN) says it is not involved in talks that could result in a merger or a takeover of the company. Previous reports had discussed interest from Johnson & Johnson (JNJ), and a new report said talks had begun with Biomet about a possible merger. Shares -1.1% in London trading. Comment!
-
Monday, January 10, 2011, 9:00 AM
Premarket gainers: PLA +17%. CNXT +16%. SNN +12%. LDK +9%. RAS +6%. ACW +5%. LXRX +5%. SPWRA +5%. XING +5%. INHX +5%. AVL +4%. SLE +4%. SHZ +4%. REE +4%. SOL +4%.
Losers: STRA -26%. APOL -9%. COCO -8%. CTIC -6%. ROVI -5%. FCEL -5%. IDX -4%. AIB -4%. Comment! - Monday, January 10, 2011, 7:50 AM Smith & Nephew (SNN) is getting a nice premarket boost after weekend reports that J&J (JNJ) made a £7B ($11B) takeover offer for the British medical equipment firm late last year, and is now considering a higher bid. SNN +11.75%. Comment!
- Sunday, January 9, 2011, 9:17 AM British medical equipment firm Smith & Nephew (SNN) reportedly rejected a £7B ($11B) takeover approach by Johnson & Johnson (JNJ) late last year, with J&J now considering whether to make a higher bid. Comment!
-
Wednesday, December 8, 2010, 9:00 AM
Premarket gainers: OREX +128%. VVUS +21%. NVIS +21%. ARNA +16%. FBP +10%. AIB +9%. IRE +8%. SNN +5%. DDMX +4%. RTK +4%.
Losers: PUDA -10%. SWC -6%. KFN -6%. JBLU -5%. MNTA -5%. GST -5%. GDOT -5%. Comment!
-
Dividend Sheet
$PFLT $KED and $MAIN are tomorrow's top yielding ex-dividend stocks - http://stks.co/gRgB - 18 Shares - 4.18% Yield $FL $VALE $CMTL $SNN - View all 0 replies
-
joe senior
$SNN I was looking at the year end information SNN just put out. Can anyone tell me the worth of this on a per-share basis? - View all 0 replies
-
- View all 0 replies
-
Dividend Sheet
Big Players: Long-Term Financial Analysis of Johnson & Johnson ++ http://t.co/9hijxHA ++ $MDT $ZMH $SNN - View all 0 replies
-
- View all 0 replies
-
Hillbilly Stock Star
DEJ......wildcatter catches a bid, hopefully they do a deal like SNN, both wildcat longs. - View all 0 replies
-
- View all 0 replies
-
- View all 0 replies
-
Andrew Shapiro
$SPA Just posted a detailed analysis of Sparton's Delphi Medical acquisition on my instablog at http://seekingalpha.com/p/1yxa $NUVA $SI $JNJ $SNN - View all 0 replies
LATEST REPLIES